C07C 62/02
Saturated compounds containing hydroxy or o-metal groups
Official title: Saturated compounds containing hydroxy or O-metal groups
C07C62/02 (Saturated compounds containing hydroxy or o-metal groups) appears on 69 US grants and 50 published applications in this corpus.
Search patents in C07C- Granted patents
- 69
- Published applications
- 50
- Assignees
- 44
- Inventors
- 162
- Latest grant
- 29 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 2 |
| 2006 | 1 | 1 |
| 2007 | 1 | 1 |
| 2008 | 4 | 2 |
| 2009 | 1 | 2 |
| 2010 | 3 | 1 |
| 2011 | 1 | 3 |
| 2012 | 4 | 3 |
| 2013 | 1 | 6 |
| 2014 | 1 | 2 |
| 2015 | 6 | 4 |
| 2016 | 1 | 0 |
| 2017 | 2 | 3 |
| 2018 | 3 | 2 |
| 2019 | 1 | 6 |
| 2020 | 2 | 1 |
| 2021 | 1 | 4 |
| 2022 | 1 | 1 |
| 2023 | 1 | 2 |
| 2024 | 1 | 0 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Isofagomine salts, methods of use and formulations29 Apr 2025US 12,286,400 B2Takeda Pharmaceutical Company Limited
- Salts and photoresists comprising same23 Jan 2024US 11,880,134 B2Rohm and Haas Electronic Materials LLC
- Cosmetic composition comprising vetiver root extract23 May 2023US 11,654,102 B2Givaudan SA
- Salts of an epidermal growth factor receptor kinase inhibitor5 Apr 2022US 11,292,772 B2Celgene CAR LLC
- Hydroxyl compounds and compositions for cholesterol management and related uses9 Mar 2021US 10,941,095 B2Esperion Therapeutics, Inc.
- Cooling compounds and compositions15 May 2025US 2025/0154123 A1V. Mane Fils
- Hydroxyl compounds and compositions for cholesterol management and related uses6 Jul 2023US 2023/0210800 A1Esperion Therapeutics, Inc.
- Isofagomine salts, methods of use and formulations13 Apr 2023US 2023/0110129 A1Takeda Pharmaceutical Company Limited
- New Kaurane analogues, their preparation and therapeutically uses30 Jun 2022US 2022/0204437 A1Key-Pharma Biomedical Inc.
- Hydroxyl compounds and compositions for cholesterol management and related uses23 Dec 2021US 2021/0395175 A1Esperion Therapeutics, Inc.
Most cited
By later US patents
- Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers102US 5,064,823 AResearch Triangle Institute · 1991
- Phosphodiesterase inhibitors42US 5,091,431 ASchering Corporation · 1992
- Thiazolidine derivatives and production thereof41US 4,461,902 ATakeda Chemical Industries, Ltd. · 1984
- Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses34US 7,405,226 B2Pfizer Inc. · 2008
- Hydroxyl compounds and compositions for cholesterol management and related uses29US 7,335,799 B2Esperion Therapeutics, Inc. · 2008